South Korea-based startup Neurophet, an artificial intelligence (AI) solution company for brain disease, has announced newl appointment of Donghyeon Kim, who is currently CTO (Chief Technology Officer), to serve as Co-Chief Executive Officer (CEO).

Donghyeon Kim established the company alongside Co-CEO Jake Junkil Been in 2016. Kim developed the next-generation neuro-navigation system, which serves as the foundation of Neurophet's technology, and has overseen Neurophet's neuroimaging analysis as CTO for the past eight years.

Kim holds approximately 100 patents in the fields of brain disease diagnosis, treatment, and analysis, and has published numerous papers in high-impact international journals such as SCI(E). Recognised for his contributions to the advancement of AI neuroimaging technology, he was awarded a commendation from the Ministry of Science and ICT last year and is currently serving as the section manager of AI division at Korea Medical Devices Industry Association Industry Development Committee.

The appointment of Co-CEO has been decided to expand Neurophet's business development capabilities and carry out a strategic management approach. Co-CEO Jake Junkil Been will lead efforts in global expansion and market penetration, while Co-CEO Donghyeon Kim will drive research and development, ensuring both external growth and internal stability. This strengthened leadership is expected to accelerate Neurophet's path to a KOSDAQ listing in the biotech sector next year.